Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;30(2):437-443.
doi: 10.1007/s11136-020-02639-7. Epub 2020 Oct 9.

Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose

Affiliations

Quality of life more than 10 years after radiotherapy for localized prostate cancer-impact of time after treatment and prescription dose

Michael Pinkawa et al. Qual Life Res. 2021 Feb.

Abstract

Purpose: Analysis of quality of life changes after radiotherapy with focus on the impact of time after treatment and prescription dose.

Methods: Consecutive patients were treated with doses from 70.2/1.8 Gy (n = 206) to 72/1.8-2.0 Gy (n = 176) in a single centre and surveyed using the Expanded Prostate Cancer Index Composite questionnaire.

Results: Urinary and bowel bother scores decreased 1 / 3 / 6 points and 7 / 7 / 9 points on average 1 / 5 / 10 years after RT in comparison to baseline scores. The rate of urinary (need of pads in 8% vs. 15% before vs. 10 years after RT; p = 0.01) and bowel (uncontrolled leakage of stool in 5% vs. 12% before vs. 10 years after RT; p < 0.01) incontinence, as well as rectal bleeding (4% vs. 8% before vs. 10 years after RT; p = 0.05) increased. Sexual function scores decreased (erections sufficient for intercourse in 36% vs. 12% before vs. 10 years after RT; p < 0.01). A higher dose had a statistically significant impact on urinary bother and stool incontinence, but also tended to decrease urinary continence. Age and comorbidities did not have an influence on score changes, but on baseline urinary function/bother and baseline sexual function.

Conclusion: Apart from an increasing rate of erectile dysfunction, urinary and bowel incontinence rates increased with increasing follow-up period. A higher dose was found to be associated with increased urinary problems and larger stool incontinence rates. Age and comorbidities were found to be relevant for baseline scores, but not for score changes.

Keywords: Conformal radiotherapy; Dose–response relationship; Prostate neoplasms; Quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Similar articles

Cited by

References

    1. Pinkawa M, Piroth MD, Holy R, Djukic V, Klotz J, Krenkel B, et al. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlentherapie und Onkologie. 2011;187(8):479–484. doi: 10.1007/s00066-011-2249-z. - DOI - PubMed
    1. Ghadjar P, Fiorino C, MunckAfRosenschold P, Pinkawa M, Zilli T, vanderHeide UA. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiotherapy and Oncology. 2019 doi: 10.1016/j.radonc.2019.08.027. - DOI - PubMed
    1. Viani GA, Stefano EJ, Afonso SL. Higher-than-conventional radiation doses in localized prostate cancer treatment: A meta-analysis of randomized, controlled trials. International Journal of Radiation Oncology Biology Physics. 2009;74(5):1405–1418. doi: 10.1016/j.ijrobp.2008.10.091. - DOI - PubMed
    1. Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer Who dies of disease? International Journal of Radiation Oncology Biology Physics. 2011;79(5):1310–1317. doi: 10.1016/j.ijrobp.2010.01.006. - DOI - PubMed
    1. Ozyigit G, Onal C, Igdem S, Alicikus ZA, Iribas A, Akin M, et al. Treatment outcomes of prostate cancer patients with Gleason score 8–10 treated with definitive radiotherapy : TROD 09–001 multi-institutional study. Strahlentherapie und Onkologie. 2019;195(10):882–893. doi: 10.1007/s00066-019-01476-z. - DOI - PubMed